Abicap – Antibody Binding Immunocolumn for Analytical Purpose
Research technology lateral flow immunoassay platform
Introduction of the first lateral flow immunoassays developed and produced by Senova
ISO 9001, ISO 13485 certification
Market launch of professional use products
Market launch of home use products
New production facility with automation line
The company Senova, which was founded in 1997, originated in ABICAP 3D immunofiltration technology, which enables quantitative, highly sensitive immunological detection of a wide variety of analytes within less than 60 minutes. The focus was primarily on analytes of the so-called “dirty dozen”, 12 agents that could potentially be used as a biological weapon.
In 2004, Senova began to specialize intensively in the technology of lateral flow assays and set up the necessary equipment and laboratory equipment for this.
In 2009/2010, Senova then expanded its portfolio with the first lateral flow strip tests. During the same period, Senova acquired parts of the historic clockwork at the city of Weimar and transformed the former administration building into a modern research and production facility that was already geared towards the special requirements for the infrastructure of a strip test production. Immediately after the initial certification as a medical device manufacturer, the company started its successful journey into the European IVD market with twelve employees.
From 2012 to 2016, the cornerstones of the Human IVD portfolio based on Lateral Flow Immunoassay technology were developed and approved with Troponin I, DDimer, CRP, hCG, Influenza A / B, Streptococcus A, microalbumin and hemoglobin. This was followed by developments of products for self-use such as the detection of ferritin levels, a rapid allergy test and many more. To date, more than 20 additional biomarkers have been established on behalf of customers and handed over to production. With the development of the first Ebola LFA worldwide, it was possible to establish a cost-effective and robust detection method that has no alternative due to the environmental conditions.
In 2018, a new production building was put into operation, which offers an automatic production line as well as space for logistics and kitassembly. Today, more than 30 employees work in a team at the site on the production of established – and the development of innovative rapid tests.